Lymphoma is one of the most common cancers in dogs. With treatment options available, understanding the welfare implications at each stage helps owners make compassionate and informed decisions.
Lymphoma welfare decisions are among the most ethically complex in small animal medicine. The relatively good quality of life during successful chemotherapy remission means that treatment can provide meaningful welfare benefit — months of comfortable, active life. However, the intensive monitoring, repeated clinic visits, and occasional acute side effects create a welfare burden that must be weighed. When remission ends, the deterioration can be rapid and painful: swollen lymph nodes, respiratory compromise, and organ failure cause clear suffering. The welfare imperative is to monitor quality of life carefully throughout, with pre-agreed thresholds for palliative transition. Palliative care with prednisolone alone can provide weeks of reasonable comfort without chemotherapy toxicity for dogs whose owners prefer a gentler approach.